Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bristol/Medarex: A Transformational Acquisition Rooted In Collaboration

Sep 18 2017

• By Joseph Haas

String of pearls_790

Related Content

Bristol Looking For Deals, Immuno-Oncology And Otherwise

Jul 24 2014

Post-MYSTIC, Bristol Renews CTLA-4 Vows, But Is "Not Wedded" In Lung Cancer

Jul 28 2017

Keytruda And The Surprising Fruits Of M&A

Sep 18 2015

With The Launch Of Yervoy, Early Signs Of R&D Success For Bristol

May 01 2011

Bristol-Myers Squibb Buys Medarex: Adds Eighth ‘Pearl' To String

Jul 27 2009

Related Companies

Bristol Myers Squibb Company

Medarex

Pfizer Inc.

Pfizer Inc.

Merck & Co., Inc.

Schering-Plough

Roche Holding AG

Genentech, Inc.

Gilead Sciences, Inc.

Pharmasset, Inc.

Additional Topics

Deals Business Strategies ImmunoOncology M & A Growth BioPharmaceutical Cancer

More from Deal-Making

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window